Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 50.793 |
|
|||||
| News | - | ||||||
| Tageshoch | 1,99 | Niedrig Hoch |
|||||
| Tagestief | 1,93 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| ProQR Therapeutics NV | PRQR | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,02 | -1,02% | 1,94 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,95 | 1,93 | 1,99 | 1,94 | 1,96 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 560 | 50.793 | US$ 1,95 | US$ 99.197 | - | 1,11 - 3,29 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:03:51 | formt | 973 | US$ 1,98 | USD |
Finanzwerte PRQR
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 157,83M | 81,35M | - | 6,59M | -28,12M | -0,35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News ProQR Therapeutics NV
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 15.2.2024 | 13:46 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 14.2.2024 | 12:08 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 09.2.2024 | 12:37 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 19.1.2024 | 13:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 05.1.2024 | 13:08 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 07.11.2023 | 16:00 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 27.9.2023 | 13:06 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 14.9.2023 | 23:20 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 03.8.2023 | 13:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 01.8.2023 | 13:15 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
Forum ProQR Therapeutics NV
Keine Diskussionen Gefunden.Neuen Thread Erstellen
PRQR Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,90 | 2,12 | 1,84 | 1,99 | 141.591 | 0,04 | 2,11% |
| 1 Monat | 2,26 | 2,46 | 1,81 | 2,09 | 165.543 | -0,32 | -14,16% |
| 3 Monate | 2,17 | 2,70 | 1,81 | 2,13 | 207.739 | -0,23 | -10,60% |
| 6 Monate | 1,23 | 3,29 | 1,11 | 2,05 | 261.652 | 0,71 | 57,72% |
| 1 Jahr | 2,24 | 3,29 | 1,11 | 1,87 | 264.241 | -0,30 | -13,39% |
| 3 Jahre | 6,18 | 9,09 | 0,53 | 2,83 | 809.861 | -4,24 | -68,61% |
| 5 Jahre | 11,23 | 13,28 | 0,53 | 4,52 | 744.825 | -9,29 | -82,72% |
